ProstACT Update: TARGET Study Ethics Approval

Go back to ProstACT Update: TARGET Study Ethics Approval
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.54 +0.77 (8.78%)
Previous Close $8.77    52 Week High $2.18 
Open $9.14    52 Week Low $0.30 
Day High $9.70    P/E N/A 
Day Low $9.14    EPS $-3.32 
Volume 463,502